Top

Journal of Hepato-Biliary-Pancreatic Sciences

Published in:

01-07-2012 | Original article

Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma

Authors: Yukiyasu Okamura, Atsuyuki Maeda, Kazuya Matsunaga, Hideyuki Kanemoto, Katsuhiko Uesaka

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 4/2012

Abstract

Background

Studies have previously indicated that surgical outcomes are poorer for obese patients. To date, few reports concerning the effect of obesity on patient outcomes following a hepatectomy for hepatocellular carcinoma (HCC) have been published. The present study, therefore, sought to determine the impact of patients’ body mass index (BMI, kg/m²) on short- and long-term surgical outcomes and to identify potential prognostic factors for HCC following a hepatectomy.

Methods

Patient data was retrospectively collected from 181 consecutive patients between September 2002 and August 2007 who had undergone hepatectomy for HCC with curative intent. Patients were assigned to three groups according to their BMI (low <18.5, standard 18.5–25, and high >25), and the clinical and pathological data, surgical outcome, and long-term survival were analyzed and compared between the three groups.

Results

The overall survival rate of the low BMI group was notably below that of the standard group. Surgical outcomes were not significantly different between the three groups. Multivariate analysis revealed that a low BMI (<18.5) is a predictor of unfavorable prognosis.

Conclusions

The present study suggests that a low BMI is a significant prognostic factor for low overall survival when performing a hepatectomy for HCC.

Berkalp B, Cesur V, Corapcioglu D, Erol C, Baskal N. Obesity and left ventricular diastolic dysfunction. Int J Cardiol. 1995;52:23–6.PubMedCrossRef

Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655–60.PubMed

Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631–6.PubMed

Wolk A, Gridley G, Svensson M, Nyren O, Mclaughlin JK, Fraumeni JF, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21.PubMedCrossRef

Lew EA, Garfinkle L. Variation in mortality by weight among 75,000 men and women. J Chronic Dis. 1979;32:563–76.PubMedCrossRef

Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5.PubMedCrossRef

Hawn MT, Bian J, Leeth RR, Ritchie G, Allen N, Bland KI, et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg. 2005;241:821–8.PubMedCrossRef

Barry JD, Blackshaw GR, Edwards P, Lewis WG, Murphy P, Hodzovic I, et al. Western body mass indices need not compromise outcomes after modified D2 gastrectomy for carcinoma. Gastric Cancer. 2003;6:80–5.PubMed

Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J. The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg. 2005;241:69–76.PubMed

10.

Tsujinaka T, Sasako M, Yamamoto S, Sano T, Kurokawa Y, Nashimoto A, et al. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007;14:355–61.PubMedCrossRef

11.

Inagawa S, Adachi S, Oda T, Kawamoto T, Koike N, Fukao K. Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer. 2000;3:141–4.PubMedCrossRef

12.

Yamanaka H, Nishi M, Kanemaki T, Hosoda N, Hioki K, Yamamoto M. Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients. JPEN. 1989;13:286–91.CrossRef

13.

Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kasaoka C. Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology. 2003;50:284–8.PubMed

14.

Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcome in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15:2164–72.PubMedCrossRef

15.

Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, et al. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010;14:1285–91.PubMedCrossRef

16.

Mathur AK, Ghaferi AA, Sell K, Sonnenday CJ, Englesbe MJ, Welling TH. Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy. J Gastrointest Surg. 2010;14:849–57.PubMedCrossRef

17.

Utsunomiya T, Okamoto M, Kameyama T, Matsuyama A, Yamamoto M, Fujiwara M, et al. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol. 2008;14:1553–8.PubMedCrossRef

18.

Caldwell SH, Crespo DM, Kang HS, AI-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:97–103.CrossRef

19.

NIH Consensus Development. Conference: statement II health implications of obesity. Ann Intern Med. 1985;103:1073–7.

20.

WHO. Obesity-preventing and managing the global epidemic. Report of WHO consultation on obesity. Geneva; 1997.

21.

Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.PubMedCrossRef

22.

Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329–36.PubMedCrossRef

23.

Mukherjee M, Sahasrabuddhe MB. Effect of operation on peripheral lymphocyte counts and production of adenosine triphosphate (ATP) in cancer patients. J Surg Oncol. 1982;20:1–8.PubMedCrossRef

24.

Roth JA, Golub SH, Grimm EA, Eilber FR, Morton DL. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Surgery. 1976;79:46–51.PubMed

25.

Sobin LH, Wittekind CH (eds) TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 81–3.

26.

The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;352:751–5.

27.

Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst. 1985;74:319–23.PubMed

28.

Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW. Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981;67:785–9.PubMed

29.

Hansson LE, Baron J, Nyrén O, Bergström R, Wolk A, Lindgren A, et al. Early-life risk indicators of gastric cancer. A population based case-control study in Sweden. Int J Cancer. 1991;57:32–7.CrossRef

30.

Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Masunaga R, et al. Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000;59:18–23.PubMedCrossRef

31.

Shiba H, Ishida Y, Wakiyama S, Iida T, Matsumoto M, Sakamoto T, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg. 2009;9:1636–42.CrossRef

32.

Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43:1295–302.PubMedCrossRef

33.

Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008;47:1856–62.PubMedCrossRef

34.

Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–40.PubMedCrossRef

35.

Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322–6.

36.

Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol. 2001;96:1243–50.PubMedCrossRef

Title: Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma
Authors: Yukiyasu Okamura
Atsuyuki Maeda
Kazuya Matsunaga
Hideyuki Kanemoto
Katsuhiko Uesaka
Publication date: 01-07-2012
Publisher: Springer Japan
Published in: Journal of Hepato-Biliary-Pancreatic Sciences / Issue 4/2012
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI: https://doi.org/10.1007/s00534-011-0461-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Negative impact of low body mass index on surgical outcomes after hepatectomy for hepatocellular carcinoma

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2012

Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center

Effect of the silk protein sericin on cryopreserved rat islets

Role of chemotherapy in treatments for biliary tract cancer

Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients

Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction